1. Rationale for targeting the Wnt signalling modulator Dickkopf‐1 for oncology
   Michael H Kagey et al, 2017, British Journal of Pharmacology CrossRef
2. A Succinate Ether Derivative of Tocotrienol Enhances Dickkopf-1 Gene Expression through Epigenetic Alterations in Malignant Mesothelioma Cells
   Ayami Sato et al, 2018, Pharmacology CrossRef
3. Casein Kinase 1α as a Regulator of Wnt-Driven Cancer
   Chen Shen et al, 2020, International Journal of Molecular Sciences CrossRef
4. Stress-activated kinases as therapeutic targets in pancreatic cancer
   Benno Traub et al, 2021, World Journal of Gastroenterology CrossRef
5. MicroRNA-1-3p inhibits the proliferation and migration of oral squamous cell carcinoma cells by targeting DKK1
   Zhenshi Wang et al, 2018, Biochemistry and Cell Biology CrossRef
6. Bone, muscle, and metabolic parameters predict survival in patients with synchronous bone metastases from lung cancers
   Lauriane Chambard et al, 2018, Bone CrossRef
7. Diagnostic investigations of DKK‐1 and PDCD5 expression levels as independent prognostic markers of human chondrosarcoma
   Mojtaba Zarea et al, 2016, IUBMB Life CrossRef
8. Targeting the Wnt Pathway in Cancer: A Review of Novel Therapeutics
   Roya Tabatabai et al, 2017, Targeted Oncology CrossRef
9. Negative regulators of Wnt signaling in non-small cell lung cancer: Theoretical basis and therapeutic potency
   Zikuan Song et al, 2019, Biomedicine & Pharmacotherapy CrossRef
10. RETRACTED ARTICLE: Dickkopf-1 contributes to hepatocellular carcinoma tumorigenesis by activating the Wnt/β-catenin signaling pathway
    Rui Zhang et al, 2019, Signal Transduction and Targeted Therapy CrossRef
11. The role of Wnt pathway antagonists in early-stage lung adenocarcinoma
    Arife Zeybek et al, 2022, Molecular Biology Reports CrossRef
12. Prognostic role of dickkopf-1 in patients with cancer
    Junfang Huang et al, 2020, Medicine CrossRef